Dr. Bourgoin is a regular researcher at the Research Center of Quebec – Laval University and Professor in the Department of Microbiology-Infectiology and Immunology of the Faculty of Medicine at Laval University. His work focuses on lipid mediators of inflammation in systemic autoimmune diseases and dysfunction of innate immunity cells.

Dr. Bourgoin has published more than 100 articles in scientific journals (Google Scholar h-index of 39). His work has been the subject of several editorial reviews of scientific journals in 2108 (Molecular Pharmacology) and in 2011 (Journal of Leukocyte Biology). Dr. Bourgoin contributes to the influence of the CHU Research Centre and Laval University by organizing international symposia on neutrophils in immunity (2012, 2014, 2016, 2018).

Understanding early atherosclerosis in rheumatic autoimmune diseases:

Accelerated atherosclerosis, associated with systemic autoimmune diseases, such as lupus erythematosus and rheumatoid arthritis, significantly increases the risk of cardiovascular events. The lipid mediators of inflammation play an amplifying role in the development of atherosclerosis, promoting the recruitment of immune system cells and the thickening of the vessel wall. Strategies to reduce cardiovascular risks associated with lupus erythematosus and rheumatoid arthritis remain to be clarified.

A new target to treat leukemia:

Myeloid leukemias are blood cancers whose origin is an anarchic production of white blood cells, from the bone marrow. These cells are usually immature, and unable to fight infections. Their presence also tends to disrupt the production of red blood cells, and cause a decline in the production of platelets. Genetic and epigenetic modifications alter the expression or function of proteins that act as positive or negative regulators of proliferation. These molecular switches abundant in leukemic myeloid cells act as positive regulators of proliferation, while inhibiting their differentiation into functional white blood cells.

CHUL
2705, boulevard Laurier
T-1-49
Québec, Québec
Canada G1V 4G2

Latest news

Data not available

95 entries « 1 of 19 »

Gendron DR, Lecours PB, Lemay AM, Beaulieu MJ, Huppe CA, Lee-Gosselin A, Flamand N, Don AS, Bissonnette E, Blanchet MR, Laplante M, Bourgoin SG, Bosse Y, Marsolais D

A Phosphorylatable Sphingosine Analog Induces Airway Smooth Muscle Cytostasis and Reverses Airway Hyperresponsiveness in Experimental Asthma.

Journal Article

Front Pharmacol, 8 , pp. 78, 2017.

Abstract | Links:

Hui W, Zhao C, Bourgoin SG

Differential Effects of Inhibitor Combinations on Lysophosphatidic Acid-Mediated Chemokine Secretion in Unprimed and Tumor Necrosis Factor-α-Primed Synovial Fibroblasts.

Journal Article

Front Pharmacol, 8 , pp. 848, 2017.

Abstract | Links:

Zhao C, Sardella A, Davis L, Poubelle PE, Bourgoin SG, Fernandes MJ

A transgenic mouse model for the in vivo bioluminescence imaging of the expression of the lysophosphatidic acid receptor 3: relevance for inflammation and uterine physiology research.

Journal Article

Transgenic Res, 24 (4), pp. 625-34, 2015, ISSN: 0962-8819.

Abstract | Links:

Gamara J, Chouinard F, Davis L, Aoudjit F, Bourgoin SG

Regulators and Effectors of Arf GTPases in Neutrophils.

Journal Article

J Immunol Res, 2015 , pp. 235170, 2015, ISSN: 2314-7156.

Abstract | Links:

Hui W, Zhao C, Bourgoin SG

LPA Promotes T Cell Recruitment through Synthesis of CXCL13.

Journal Article

Mediators Inflamm, 2015 , pp. 248492, 2015, ISSN: 0962-9351.

Abstract | Links:

95 entries « 1 of 19 »

Active projects

  • Centre hospitalier universitaire de Québec - CHU de Québec-Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis., Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2015-07-01 to 2020-06-30

Recently finished projects

  • Regulation of neutrophil functions by the cytohesin-Arf6 signaling axis, Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2012-01-01 to 2017-03-31
Data provided by the Université Laval research projects registery